These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7007988)

  • 1. Is the therapy with carbamazepine more effective when measuring blood levels?
    Tatzer E; Groh C
    Padiatr Padol; 1980; 15(4):293-6. PubMed ID: 7007988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
    Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK
    Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
    Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbamazepine dosage and its blood serum level in children].
    Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
    Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
    Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
    Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
    Vasudev A; Tripathi KD; Puri V
    Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monotherapy in epilepsy: relations between clinical effects and plasma levels of the drug in patients treated only with carbamazepine].
    Monaco F; Riccio A; Gerna M; Morselli PL
    Acta Neurol (Napoli); 1975; 30(5):530-9. PubMed ID: 779411
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.
    Grabenstatter HL; Clark S; Dudek FE
    Epilepsia; 2007 Dec; 48(12):2287-95. PubMed ID: 17711461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine therapy and long-term prognosis in epilepsy of childhood.
    Okuno T; Ito M; Nakano S; Hattori H; Fujii T; Go T; Mikawa H
    Epilepsia; 1989; 30(1):57-61. PubMed ID: 2912717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment].
    Okudzhava VM; Antadze ZI; Chankvetadze BG; Vetrogon FG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1327-9. PubMed ID: 3425074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.